The Europe Veterinary Diagnostics Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030).
Veterinary diagnostics entails identifying and quantifying compounds in non-human animal source materials. Clinical evaluation must be included in veterinary diagnostics. It empowers the veterinarian with the knowledge to identify the disease or conditions responsible for the clinical abnormalities. Increased spending on animal health, a rise in the number of zoonotic diseases and veterinarians, advancements in point-of-care diagnostic technology, and rising disposable income in developing nations have all contributed to the expansion of the market.
In addition, the clinical examination results should aid the veterinarian in determining the severity of pathophysiological processes. Veterinarians use various veterinary technologies to identify diseases, track disease progression or treatment response, and examine animals that appear to be in good condition for underlying problems. Due to the expanding prevalence of infectious animal diseases, demand is expected to increase further. In addition, improvements in diagnostics and the growing adoption of novel procedures in most laboratories contribute to market expansion.
Europe has diverse animal species, and some diseases can devastate animals and the economy. It plays a vital role in surveillance efforts to monitor and control diseases, including zoonotic diseases that can affect humans. These are essential for monitoring and maintaining the health of animals. Routine check-ups, diagnostic tests, and screenings help detect diseases, infections, and other animal health issues early, enabling timely treatment and prevention. Sheep breeding stock prices, an essential source of income on upland farms, are also expected to be higher compared to 2019. Due to the growth of the livestock industry in this region, it is expected that the market will expand significantly in this region.
The Germany market dominated the Europe Veterinary Diagnostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.0 billion by 2030. The UK market is estimated to grow at a CAGR of 9.1% during (2023 - 2030). Additionally, The France market would witness a CAGR of 10.8% during (2023 - 2030).
Based on Product, the market is segmented into Consumables, Reagents & Kits, Instruments & Devices. Based on End Use, the market is segmented into Laboratories, Veterinary Hospitals & Clinics, Point-Of-Care/In-House Testing, Research Institutes & Universities. Based on Disease Type, the market is segmented into Non-Infectious Diseases, General Ailments, Infectious Diseases, Hereditary, Congenital & Acquired Diseases, and Others. Based on Testing Type, the market is segmented into Pathology, Bacteriology & Molecular Diagnostics, Diagnostic Imaging, Immunoassays, Parasitology, Serology & Virology and Analytical Services. Based on Species, the market is segmented into Canine, Avian, Ovine, Equine, Cattle, Caprine, Feline, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Veterinary Diagnostics Market is Projected to reach USD 15.6 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Heska Corporation (Antech Diagnostics, Inc), IDEXX Laboratories Inc., Agrolabo S.p.A., Innovative Diagnostics SAS (Idvet), Virbac, Thermo Fisher Scientific, Inc., Neogen Corporation, Covetrus, Inc. (Clayton, Dubilier & Rice, LLC), and iM3 Pty Ltd
By Product
By End Use
By Disease Type
By Testing Type
By Species
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
